Secondary Logo

Journal Logo

Articles by Chi-Jen Chu

Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis

Su, Pin-Shuo; Wu, Sih-Hsien; Chu, Chi-Jen; More

Journal of the Chinese Medical Association. 85(2):152-159, February 2022.

Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus–coinfected patients treated by all-oral direct-acting antivirals

Su, Pin-Shuo; Su, Chien-Wei; Wu, Sih-Hsien; More

Journal of the Chinese Medical Association. 84(5):465-471, May 2021.

Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response

Hsieh, Yun-Cheng; Lee, Kuei-Chuan; Su, Chien-Wei; More

Journal of the Chinese Medical Association. 84(5):472-477, May 2021.

Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation

Wu, Sih-Hsien; Loong, Che-Chuan; Chu, Chi-Jen; More

Journal of the Chinese Medical Association. 83(1):18-24, January 2020.

Higher platelet counts are associated with metabolic syndrome independent of fatty liver diagnosis

Fang, Kuan-Chieh; Cheng, Yuan-Lung; Su, Chien-Wei; More

Journal of the Chinese Medical Association. 80(3):125-132, March 2017.